Drug Profile
Anakinra biosimilar - Axxo
Latest Information Update: 23 Dec 2021
Price :
$50
*
At a glance
- Originator AXXO
- Class Anti-infectives; Anti-inflammatories; Antibacterials; Antigouts; Antineoplastics; Antirheumatics; Recombinant proteins
- Mechanism of Action Immunomodulators; Interleukin 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase Unknown Rheumatoid arthritis
Most Recent Events
- 17 Sep 2013 Investigation for Rheumatoid arthritis in Germany (Parenteral)